| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
-Exon Inclusion1
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center [W. J., I. G. B., T-X. X., L. J. S., G. J. C.], and The University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030 [I. G. B., G. J. C.]
Exclusion of the
-exon by alternative RNA splicing of the fibroblast growth factor receptor 1 (FGFR1) primary transcript leads to the production of FGFR1ß. Glial cell transformation is associated with a progressive increase in FGFR1ß expression that coincides with a dramatic increase in the expression of the splicing factor polypyrimidine tract-binding protein (PTB). Cell-specific overexpression of PTB increased
-exon skipping, and a reduction in PTB increased
-exon inclusion. Targeted disruption of PTB interaction with FGFR1 precursor RNA in vivo by an antisense oligonucleotide also increased
-exon inclusion. These results suggest that PTB plays a direct role in
-exon splicing.
This article has been cited by other articles:
![]() |
C. Wang, J. T. Norton, S. Ghosh, J. Kim, K. Fushimi, J. Y. Wu, M. S. Stack, and S. Huang Polypyrimidine Tract-binding Protein (PTB) Differentially Affects Malignancy in a Cell Line-dependent Manner J. Biol. Chem., July 18, 2008; 283(29): 20277 - 20287. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Swinburne, C. A. Meyer, X. S. Liu, P. A. Silver, and A. S. Brodsky Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription Genome Res., July 1, 2006; 16(7): 912 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. AMIR-AHMADY, P. L. BOUTZ, V. MARKOVTSOV, M. L. PHILLIPS, and D. L. BLACK Exon repression by polypyrimidine tract binding protein RNA, May 1, 2005; 11(5): 699 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Jin and G. J. Cote Enhancer-Dependent Splicing of FGFR1 {alpha}-Exon Is Repressed by RNA Interference-Mediated Down-Regulation of SRp55 Cancer Res., December 15, 2004; 64(24): 8901 - 8905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Venables Aberrant and Alternative Splicing in Cancer Cancer Res., November 1, 2004; 64(21): 7647 - 7654. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Bruno, W. Jin, and G. J. Cote Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements Hum. Mol. Genet., October 1, 2004; 13(20): 2409 - 2420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |